ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 79

$775K Total Retail Price of All Prescriptions

Rank: 14 out of 79

256 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 256 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 10,722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 456 455 1 4
SIMVASTATIN 426 387 2 3
LEVOTHYROXINE SODIUM 414 386 3 1
NAMENDA 396 371 4 9
LISINOPRIL 373 344 5 2
HYDROCODONE-ACETAMINOPHEN 344 341 S3 6 5
DONEPEZIL HCL 321 306 7 8
OMEPRAZOLE 290 270 8 7
KLOR-CON M20 241 239 9 63
AMLODIPINE BESYLATE 219 189 10 6
WARFARIN SODIUM 217 211 11 14
MIRTAZAPINE 205 201 12 15
TRAMADOL HCL 201 199 13 17
POTASSIUM CHLORIDE 179 179 14 11
ALENDRONATE SODIUM 173 171 15 32
ESCITALOPRAM OXALATE 161 145 16 25
ATORVASTATIN CALCIUM 161 147 16 30
LIDODERM 157 147 18 55
CARVEDILOL 156 122 19 21
METOPROLOL TARTRATE 146 146 20 10
CITALOPRAM HBR 144 144 21 18
METFORMIN HCL 139 113 22 13
METOPROLOL SUCCINATE 139 139 22 23
GABAPENTIN 136 134 24 12
NOVOLOG 135 106 25 66
CARBIDOPA-LEVODOPA 118 117 26 44
JANTOVEN 105 83 27 91
PREDNISONE 103 101 28 54
CYMBALTA 103 84 28 27
HUMALOG 101 92 30 118
MELOXICAM 101 101 30 52
PANTOPRAZOLE SODIUM 91 91 32 37
SERTRALINE HCL 89 54 33 16
LACTULOSE 88 81 34 40
DIGOXIN 86 86 35 42
PRAVASTATIN SODIUM 86 86 35 38
EXELON 84 75 37 41
RISPERIDONE 79 63 38 24
HUMULIN N 78 70 39 225
PHENYTOIN 76 76 40 128
QUETIAPINE FUMARATE 75 64 41 20
ZOLPIDEM TARTRATE 69 58 42 28
LANTUS 68 58 43 26
LYRICA 66 46 44 73
NOVOLIN N 64 52 45 241
NEXIUM 63 52 46 34
FAMOTIDINE 63 63 46 60
ALBUTEROL SULFATE 62 60 48 50
GLIPIZIDE XL 60 59 49 247
OLANZAPINE 60 50 49 57
METOCLOPRAMIDE HCL 58 44 51 93
DIVALPROEX SODIUM 55 52 52 29
NYSTATIN 52 51 53 80
CLOPIDOGREL 52 46 53 31
FLUTICASONE PROPIONATE 51 50 55 47
DIOVAN 50 50 56 56
LOSARTAN POTASSIUM 50 45 56 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.